Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution. Based on its startup operational expertise, product development experience, and globally recognized strategic analysis, it has developed a blueprint for building and deploying technological capabilities that will become a critical
infrastructure of the 21st-century economy.
The company`s proprietary blueprint is the distillation of the fund managers` five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, EdenWorks, and Lumen Biosciences.
Industries: Energy
Renewable Energy
Solar
Biotechnology
Information Services
Information Technology
Manufacturing
Bioinformatics
Genetics
Life Science
Biopharma
Medical
Medical Device
Industrial Automation
Internet of Things
Pharmaceutical
Software
Machine Learning
Location: Seattle, Washington, United States
